Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 3.2.2023GlaxoSmithKline Trading Services Limited (GAG-IRL-3)12494Augmentin 1 g (tbl flm 14x1 g (blis.Al/PVC/PVDC))26.1.2023R
 3.2.2023GlaxoSmithKline Trading Services Limited (GAG-IRL-3)93709Augmentin 375 mg (tbl flm 21x375 mg (blis.PVC/PVDC/Al))26.1.2023R
 3.2.2023MEDOCHEMIE Ltd. (MOE)2791CVERRIA 200 mg filmom obalené tablety (tbl flm 14x200 mg (blis.PVC/Al))1.2.2023R
 3.2.2023MEDOCHEMIE Ltd. (MOE)37099ARKETIS 20 mg (tbl 30x20 mg (blis.PVC/Al))1.2.2023R
 3.2.2023MEDOCHEMIE Ltd. (MOE)37101ARKETIS 20 mg (tbl 60x20 mg (blis.PVC/Al))1.2.2023R
 3.2.2023MEDOCHEMIE Ltd. (MOE)37109ARKETIS 30 mg (tbl 30x30 mg (blis.PVC/Al))1.2.2023R
 3.2.2023MEDOCHEMIE Ltd. (MOE)8708DBROXIVAN 6 mg/ml perorálny roztok (sol por 1x200 ml/1200 mg (fľ.skl.hnedá+plast.odmer.))1.2.2023O
 3.2.2023MEDOCHEMIE Ltd. (MOE)8735DBROXIVAN 3 mg/ml perorálny roztok (sol por 1x100 ml/300 mg (fľ.skl.hnedá+plast.odmer.))1.2.2023O
 3.2.2023MEDOCHEMIE Ltd. (MOE)9445BZEPILEN 1 g (plo ijf 10x1 g (liek.inj.skl.))1.2.2023O
 2.2.2023Merck Santé s.a.s (MES)37586GLUCOPHAGE XR 750 mg (tbl plg 60x750 mg (blis.PVC/PVDC/Al))2.2.2023R
 2.2.2023Bausch + Lomb Ireland Limited (BUS)93027ARUFIL (int opo 3x10 ml (fľ.PE))1.2.2023O
 2.2.2023Bausch + Lomb Ireland Limited (BUS)1222CARUFIL (int opo 3x10 ml (fľ.LDPE-biela))1.2.2023O
 2.2.2023Guerbet (GUT-2)24742MICROPAQUE (sus pre 1x2000 ml (fľ.PE))15.2.2023O
 2.2.2023URSAPHARM Arzneimittel GmbH (URS-1)83772Kanamycin-POS (int opo 1x5 ml (fľ.PE))3.2.2023O
 2.2.2023McNeil Healthcare (Ireland) Limited (MCP-2)2529AImodium Instant (tbl oro 6x2 mg (blis.papier/PET/Al/PVC/PA))2.2.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)